BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23700058)

  • 1. The principle and practice of reinduction therapy (in ALL): repetita iuvant!
    Masera G; Conter V; Gaynon PS
    Klin Padiatr; 2013 May; 225 Suppl 1():S57-61. PubMed ID: 23700058
    [No Abstract]   [Full Text] [Related]  

  • 2. Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000.
    Schrappe M; Möricke A; Reiter A; Henze G; Welte K; Gadner H; Ludwig WD; Ritter J; Harbott J; Mann G; Klingebiel T; Gruhn B; Niemeyer C; Kremens B; Niggli F; Debatin KM; Ratei R; Stanulla M; Beier R; Cario G; Schrauder A; Zimmermann M
    Klin Padiatr; 2013 May; 225 Suppl 1():S62-72. PubMed ID: 23700060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once upon a time--a personal view on episodes in leukemia research in Germany, and beyond.
    Gaynon P
    Klin Padiatr; 2013 May; 225 Suppl 1():S5. PubMed ID: 23700056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prof. Dr. Hansjörg Riehm, a life devoted to science].
    Klingebiel T; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S9-14. PubMed ID: 23700067
    [No Abstract]   [Full Text] [Related]  

  • 5. [Greetings from the SIOP].
    Calaminus G
    Klin Padiatr; 2013 May; 225 Suppl 1():S8. PubMed ID: 23700064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Greetings from the Society of Pediatric Oncology and Hematology (GPOH)].
    Eggert A
    Klin Padiatr; 2013 May; 225 Suppl 1():S7. PubMed ID: 23700061
    [No Abstract]   [Full Text] [Related]  

  • 7. 50 Years Ago in The Journal of Pediatrics: A Study of "Total Therapy" of Acute Lymphocytic Leukemia in Children.
    Ferguson WS
    J Pediatr; 2018 Mar; 194():115. PubMed ID: 29478493
    [No Abstract]   [Full Text] [Related]  

  • 8. Old man river. The flow of pediatric oncology.
    D'Angio GJ; Vietti TJ
    Hematol Oncol Clin North Am; 2001 Aug; 15(4):599-607, vii. PubMed ID: 11676275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3.
    Lichtman MA
    Blood Cells Mol Dis; 2013 Feb; 50(2):119-30. PubMed ID: 23154039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Greetings from DGKJ].
    Wagner N
    Klin Padiatr; 2013 May; 225 Suppl 1():S6. PubMed ID: 23700059
    [No Abstract]   [Full Text] [Related]  

  • 11. 50 Years Ago in The Journal of Pediatrics: Sequential Therapy of Acute Leukemia in Childhood.
    Heikamp E; Rau R
    J Pediatr; 2017 Apr; 183():140. PubMed ID: 28343531
    [No Abstract]   [Full Text] [Related]  

  • 12. The life and work of Professor Riehm from a participant's perspective.
    Gadner H
    Klin Padiatr; 2013 May; 225 Suppl 1():S3-4. PubMed ID: 23700052
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Büyükçelik A; Yalçin B; Utkan G; Doruk H
    Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in the field of hematology in the last 100 years: Medical history of acute leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2084-9. PubMed ID: 12187682
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forty-five-year follow-up of a childhood leukemia survivor: serendipity or karma?
    Ravindranath Y
    Med Pediatr Oncol; 1999 Oct; 33(4):409-10. PubMed ID: 10491554
    [No Abstract]   [Full Text] [Related]  

  • 17. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children].
    Rokicka-Milewska R; Derulska D; Skwarska E
    Pol Tyg Lek; 1988 Aug; 43(34):1085-7. PubMed ID: 3150782
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.